Biomarkers are molecules found in the body that serve as indicators of a state, a disease or a condition. In drug development, biomarkers can serve as surrogates for the assessment of candidate drugs, where they can be used to validate targets, prove mechanisms of action, predicting efficacy and finding potential toxicity.
A biomarker service tailored to your needs
We offer you a complete biomarker service tailored to your drug development project. In addition to practical, technical and scientific support, Wieslab Bioanalytical Services can help you from start to finish in finding the optimal solution that fits your project needs and budget. We know that each project has unique requirements that need to be catered to when forming a project strategy.
Our expert service scientists in combination with our portfolio of over 250 immunology markers put us in a unique position to perform sample analysis of biomarker protein concentration levels in nonclinical and clinical settings that meet your expectations concerning reporting times, sample handling and storage conditions. The platforms we apply in biomarker studies are typically MSD, ELISA and SIMOA.